… The detailed mechanism of autologous bone marrow stem cell transplantation for patients
undergoing coronary artery bypass grafting has not been … Bone marrow mononuclear cells …

… combination of keywords including “myocardial infarction”, “coronary artery disease”, “stem
cell”, “mononuclear cell”, “bone marrow”, and “heart failure”. Articles in English with no further …

… Heart failure (HF) is a major complication of acute myocardial infarction (AMI). Transplantation
of bone marrow mononuclear cells (BM-MNC) in the setting of AMI has been proposed as …

… In previous clinical studies, the trend for major amputation in patients with CLI after bone
marrow mononuclear cell (BM-MNC) implantation decreased in patients with atherosclerotic …

… of autologous BMSCs in patients undergoing transmyocardial revascularization (TMR) or
coronary artery bypass graft … , floating portion of the mononuclear cells was washed away by …

… improvement after autologous bone marrow mononuclear cells transplantation in … coronary
artery bypass graft combined with bone marrow mononuclear cells delivered through a graft …

… Cell therapy using intramuscular injections of autologous bone-marrow mononuclear cells
(… limb amputation in atherosclerotic peripheral arterial disease (PAD) patients with critical limb …

… Peripheral artery disease (PAD) is a part of non-coronary artery syndrome caused by
changes in the lower extremities’ arterial structure and function, which atherosclerotic lesion and …

… cells, skeletal muscle myoblasts, cardiac stem/progenitor cells, and bone marrow mononuclear
cells … -MSCs were transplanted into coronary arteries, and the number of cell survival was …

… transplantation during coronary artery bypass graft (CABG) surgery. BMMC therapy or
placebo were administered as 15–20 0.2-ml injections into predefined sites in the infarction …